NEJM at AHA - CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/64E40DF8.svg?ark=w1%2F20260515%2F64E40DF8)](https://nobleid.org/work/w1/20260515/64E40DF8)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors